| Code: MTA11865 | Publication Date: Apr 2026 |
China acetaminophen market is characterized by the by the substantial presence of specialized manufacturers and domestic pharmaceutical leaders, each vying for market share through advanced formulation R&D and cost-effective manufacturing processes. Major companies in the market include Shandong Xinhua Pharmaceutical, Anhui BBCA Pharmaceuticals, Hebei Jiheng Group, and Zhejiang Kangle Pharmaceutical.
For detailed forecasts, data tables, and competitive benchmarking,
Explore the full China acetaminophen market.
According to 6Wresearch, the China acetaminophen market is projected for significant expansion during the current forecast period. This growth is driven by the rising prevalence of chronic pain conditions, an aging population, and China’s role as the global pharmacy, contributing a vast majority of the world’s total paracetamol output. The market is increasingly impacted by a shift toward high-purity direct compression granules and a transition from traditional batch processing to continuous, automated synthesis to meet the strict international production standards.
The competitive landscape of the China acetaminophen market is characterized by the existence of large-scale state-owned firms, nimble chemical innovators, and global corporations. To meet the growing industrial demand for high-purity pharmaceutical ingredients, these organizations invest substantially in R&D for automated continuous-flow synthesis and advanced direct compression granules.
Below is a list of leading players operating in the China Acetaminophen Market:
| Company Name | Shandong Xinhua Pharmaceutical Co., Ltd. |
|---|---|
| Established Year | 1943 |
| Headquarters | Zibo, Shandong |
| Official Website | Click Here |
The world's largest production base for antipyretics and analgesics, Shandong Xinhua is a critical global supplier of acetaminophen API and finished formulations.
| Company Name | Anhui BBCA Pharmaceuticals Co., Ltd. |
|---|---|
| Established Year | 1997 |
| Headquarters | Hefei, Anhui |
| Official Website | Click Here |
BBCA is a leading high-tech manufacturer known for its massive annual capacity and strong presence in both domestic and international OTC markets.
| Company Name | Hebei Jiheng Pharmaceutical Co., Ltd. |
|---|---|
| Established Year | 1996 |
| Headquarters | Hengshui, Hebei |
| Official Website | - |
A dominant player in the API sector with an annual paracetamol capacity of 25,000 tons and a finished tablet output reaching 5 billion units per year.
| Company Name | Zhejiang Kangle Pharmaceutical Co., Ltd. |
|---|---|
| Established Year | 1988 |
| Headquarters | Wenzhou, Zhejiang |
| Official Website | - |
Specializes in high-quality paracetamol powder and DC granules, holding multiple international certifications including US-FDA and EU-CEP.
| Company Name | Anqiu Lu’an Pharmaceutical Co., Ltd. |
|---|---|
| Established Year | 1998 |
| Headquarters | Anqiu, Shandong |
| Official Website | Click Here |
A major manufacturer focusing on large-scale API production, Lu’an is a key contributor to the global supply of pharmaceutical-grade acetaminophen.
| Company Name | Qilu Pharmaceutical Co., Ltd. |
|---|---|
| Established Year | 1958 |
| Headquarters | Jinan, Shandong |
| Official Website | Click Here |
One of China’s largest pharmaceutical groups, Qilu operates extensive synthesized API lines and maintains a vast global distribution network.
| Company Name | Hubei Biocause Pharmaceutical Co., Ltd. |
|---|---|
| Established Year | 1993 |
| Headquarters | Jingmen, Hubei |
| Official Website | Click Here |
A key player in the analgesics segment, Biocause is recognized for its technical innovation and consistent supply of high-purity chemical APIs.
| Company Name | Changshu Huagang Pharmaceutical Co., Ltd. |
|---|---|
| Established Year | 1992 |
| Headquarters | Changshu, Jiangsu |
| Official Website | Click Here |
Huagang is a specialized firm focusing on the synthesis of pharmaceutical intermediates and acetaminophen APIs for the export market.
| Company Name | Zhejiang Jingxin Pharmaceutical Co., Ltd. |
|---|---|
| Established Year | 1990 |
| Headquarters | Shaoxing, Zhejiang |
| Official Website | Click Here |
A major publicly traded company that integrates API production with high-end formulation manufacturing under strict cGMP guidelines.
| Company Name | Grand Pharmaceutical Co., Ltd. |
|---|---|
| Established Year | 1939 |
| Headquarters | Wuhan, Hubei |
| Official Website | Click Here |
A comprehensive pharmaceutical giant with a strong presence in the respiratory and analgesic markets, producing millions of paracetamol tablets monthly.
| Company Name | Anhui Topsun Pharmaceutical Co., Ltd. |
|---|---|
| Established Year | 2001 |
| Headquarters | Fuyang, Anhui |
| Official Website | Click Here |
Topsun is a rising leader in the OTC sector, focusing on accessible, high-volume generic medications and modern manufacturing technologies.
| Company Name | Sino Chemical Co., Ltd. |
|---|---|
| Established Year | 1994 |
| Headquarters | Shanghai, China |
| Official Website | Click Here |
A vital link in the chemical supply chain, specializing in the trade and manufacturing of pharmaceutical raw materials and paracetamol APIs.
| Company Name | Joincare Pharmaceutical Group |
|---|---|
| Established Year | 1992 |
| Headquarters | Shenzhen, Guangdong |
| Official Website | Click Here |
Through its subsidiary Taitai Pharma, Joincare manages an extensive portfolio of analgesic raw materials and healthcare products.
| Company Name | Hubei Gedian Humanwell Pharmaceutical Co., Ltd. |
|---|---|
| Established Year | 2000 |
| Headquarters | Wuhan, Hubei |
| Official Website | Click Here |
A subsidiary of the Humanwell Group, this firm specializes in high-quality synthesized APIs and central nervous system medications.
| Company Name | Huzhou Konch Pharmaceutical Co., Ltd. |
|---|---|
| Established Year | 1993 |
| Headquarters | Huzhou, Zhejiang |
| Official Website | - |
Konch is an established manufacturer providing specialized pharmaceutical intermediates and acetaminophen formulations for global generic drug makers.